Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CHALLENGES OF TREATMENT-RESISTANT DEPRESSION
James Paul Pandarakalam
Psychiatria Danubina (2018) Vol. 30, Iss. 3, pp. 273-284
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression
Eleni Pitsillou, Sarah M. Bresnehan, Evan A. Kagarakis, et al.
Molecular Biology Reports (2019) Vol. 47, Iss. 1, pp. 753-770
Closed Access | Times Cited: 157
Potential Mechanisms and Clinical Effectiveness of Acupuncture in Depression
Nana Yang, Lu‐Lu Lin, Yue-Jie Li, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 4, pp. 738-750
Open Access | Times Cited: 75
A Review on Potential Footprints of Ferulic Acid for Treatment of Neurological Disorders
Surabhi Thapliyal, Tanveer Singh, Shailendra Handu, et al.
Neurochemical Research (2021) Vol. 46, Iss. 5, pp. 1043-1057
Closed Access | Times Cited: 56
Moderators of Cognitive Behavioral Treatment for Insomnia on Depression and Anxiety Outcomes
Riya Mirchandaney, Raul Barete, Lauren D. Asarnow
Current Psychiatry Reports (2022) Vol. 24, Iss. 2, pp. 121-128
Open Access | Times Cited: 54
Paeonia lactiflora Pall. Polysaccharide alleviates depression in CUMS mice by inhibiting the NLRP3/ASC/Caspase-1 signaling pathway and affecting the composition of their intestinal flora
Zijun Zhou, Yuliang Wang, Shiqing Sun, et al.
Journal of Ethnopharmacology (2023) Vol. 316, pp. 116716-116716
Closed Access | Times Cited: 23
Mitochondrial Metabolism in Major Depressive Disorder: From Early Diagnosis to Emerging Treatment Options
Ane Larrea, Laura Sánchez-Sánchez, Eguzkiñe Díez-Martín, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1727-1727
Open Access | Times Cited: 8
The burden and the challenge of treatment-resistant depression
Charalampos Touloumis
Psychiatriki (2021) Vol. 32, Iss. Supplement 1, pp. 11-14
Open Access | Times Cited: 52
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
Amaya Austrich-Olivares, María S. García‐Gutiérrez, Lucía Illescas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 473-473
Open Access | Times Cited: 33
Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine
Fabiola Stolfi, Hugo Abreu, Riccardo Sinella, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Treatment-resistant depression: molecular mechanisms and management
Mayanja Kajumba, Angelina Kakooza‐Mwesige, Noeline Nakasujja, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 6
Protective effect of Convolvulus pluricaulis against neuroinflammation associated depressive behavior induced by chronic unpredictable mild stress in rat
Girdhari Lal Gupta, Joneth Fernandes
Biomedicine & Pharmacotherapy (2018) Vol. 109, pp. 1698-1708
Open Access | Times Cited: 51
QbD-driven development of intranasal lipid nanoparticles for depression treatment
Carla Vitorino, Soraia Silva, Filipa Gouveia, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 153, pp. 106-120
Open Access | Times Cited: 47
Stress-Related Dysfunction of Adult Hippocampal Neurogenesis—An Attempt for Understanding Resilience?
Julia Leschik, Beat Lutz, Antonietta Gentile
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7339-7339
Open Access | Times Cited: 36
Various neuromodulation methods including Deep Brain Stimulation of the medial forebrain bundle combined with psychopharmacotherapy of treatment-resistant depression—Case report
Joanna Rymaszewska, Tomasz Wieczorek, Karolina Fila-Witecka, et al.
Frontiers in Psychiatry (2023) Vol. 13
Open Access | Times Cited: 16
Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis
Debora de A. Simoes Moreira, Luís Eduardo Gauer, Guilherme Teixeira, et al.
Journal of Affective Disorders (2023) Vol. 330, pp. 227-238
Open Access | Times Cited: 14
Low-intensity focused ultrasound ameliorates depression-like behaviors associated with improving the synaptic plasticity in the vCA1-mPFC pathway
Faqi Wang, Qiuquan Cai, Rongfang Ju, et al.
Cerebral Cortex (2023) Vol. 33, Iss. 12, pp. 8024-8034
Closed Access | Times Cited: 13
Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression
Philip Borsellino, Reese I. Krider, Deanna Chea, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 742-742
Open Access | Times Cited: 13
Clinical characteristics of treatment-resistant depression in adults in Hungary: Real-world evidence from a 7-year-long retrospective data analysis
Péter Döme, Péter Kunovszki, Péter Takács, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245510-e0245510
Open Access | Times Cited: 32
Systematic Review of Functional MRI Applications for Psychiatric Disease Subtyping
Lucas Miranda, Riya Paul, Benno Pütz, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 32
Possible oxytocin-related biomarkers in anxiety and mood disorders
Seoyoung Yoon, Yong‐Ku Kim
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 116, pp. 110531-110531
Closed Access | Times Cited: 21
EEG alpha activity as predictor for TBS-rTMS treatment outcome in Depression
Barbora Provaznikova, Anna Monn, Erich Seifritz, et al.
Journal of Psychiatric Research (2025) Vol. 182, pp. 4-12
Closed Access
Bambusa vulgaris Extract: A Potential Natural Biogenic Amine Neurotransmitters Modulator, COX-2 Inhibitor and Oxidative Species Suppressor for Managing Depression and Anxiety
Akanji A. Murtala, Elijah O. Oyinloye, Farouk Adedeji Oladoja, et al.
Natural Product Communications (2025) Vol. 20, Iss. 1
Open Access
Trends in Prevalent Cases and Disability‐Adjusted Life‐Years of Depressive Disorders Worldwide: Findings From the Global Burden of Disease Study From 1990 to 2021
Xiao-dan Chen, Feng Li, Hui Zuo, et al.
Depression and Anxiety (2025) Vol. 2025, Iss. 1
Open Access
Associations between Autoimmunity and Depression: Serum IL-6 and IL-17 Have Directly Impact on the HAMD Scores in Patients with First-Episode Depressive Disorder
Lijuan Mao, Xiajin Ren, Xin Wang, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-6
Open Access | Times Cited: 18
An overview of the molecular and physiological antidepressant mechanisms of physical exercise in animal models of depression
Lucas Renan Sena de Oliveira, Frederico Sander Mansur Machado, Isabella Rocha-Dias, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 6, pp. 4965-4975
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top